Overview

Docetaxel in Treating Patients With Advanced Cancer of the Cervix

Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of docetaxel in treating patients with advanced cancer of the cervix.
Phase:
Phase 2
Details
Lead Sponsor:
Grupo Oncologico Cooperativo del Sur
Treatments:
Docetaxel